Nanna Therapeutics

Cambridge, United Kingdom Founded: 2012 • Age: 14 yrs Acquired By Astellas Pharma
In-vitro directed evolution platform is provided for drug discovery.

About Nanna Therapeutics

Nanna Therapeutics is a company based in Cambridge (United Kingdom) founded in 2012 was acquired by Astellas Pharma in April 2020.. The company has 14 employees as of January 31, 2018. Nanna Therapeutics operates in a competitive market with competitors including Rheonix, Phoremost, 64x Bio, Adaptyv Biosystems and reMYND, among others.

  • Headquarter Cambridge, United Kingdom
  • Employees 14 as on 31 Jan, 2018
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Nanna Therapeutics Limited
  • Date of Incorporation 12 Dec, 2012
  • Jurisdiction CAMBRIDGE
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $1.08 M (USD), Grant

    Apr 09, 2019

  • Investors
    Gov.uk

    & 2 more

  • Employee Count
    14

    as on Jan 31, 2018

  • Acquired by
    Astellas Pharma

    (Apr 22, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Nanna Therapeutics
Headcount 10-50
Employee Profiles 14
Board Members and Advisors 5
Employee Profiles
People
Chris Doe
Site Head

Unlock access to complete

Board Members and Advisors
people
Doug Turnbull
Scientific Advisor
people
Dave Spring
Scientific Advisor
people
Pietro Lio
Scientific Advisor

Unlock access to complete

Funding Insights of Nanna Therapeutics

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $1.1M
  • First Round

    (01 Jul 2015)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2019 Amount Grant - Nanna Therapeutics Valuation

investors

Jul, 2015 Amount Grant - Nanna Therapeutics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Nanna Therapeutics

Nanna Therapeutics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Gov.uk, Astellas Pharma and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Online government services and information are provided to users.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Generic pharmaceuticals are developed, manufactured, and marketed worldwide.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Nanna Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Nanna Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nanna Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Nanna Therapeutics

Nanna Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rheonix, Phoremost, 64x Bio, Adaptyv Biosystems and reMYND, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Instruments for automated molecular assays are developed using disposable cartridges.
domain founded_year HQ Location
Phenotypic screening platform developed to identify drug targets and pathways.
domain founded_year HQ Location
Cell and gene therapies for multiple diseases are developed.
domain founded_year HQ Location
Protein design, synthesis, testing, and validation services are offered.
domain founded_year HQ Location
Developer of a drug pipeline programs for neurodegenerative diseases
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nanna Therapeutics

Frequently Asked Questions about Nanna Therapeutics

When was Nanna Therapeutics founded?

Nanna Therapeutics was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Where is Nanna Therapeutics located?

Nanna Therapeutics is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

How many employees does Nanna Therapeutics have?

As of Jan 31, 2018, the latest employee count at Nanna Therapeutics is 14.

What does Nanna Therapeutics do?

Nanna Therapeutics was founded in 2012 in Cambridge, United Kingdom, and operates within the biotechnology sector focused on drug discovery. An in-vitro directed evolution platform is offered, featuring microtiter plate-based screening through Bactevos TarGET technology. Engineered microbes are combined with ultra-high-throughput microfluidic phenotypic screening, alongside specialized transposon libraries, next-generation sequencing, proprietary data-sorting algorithms, and rapid functional screening to identify molecules exhibiting desired phenotypes.

Who are the top competitors of Nanna Therapeutics?

Nanna Therapeutics's top competitors include 64x Bio, Phoremost and reMYND.

Who are Nanna Therapeutics's investors?

Nanna Therapeutics has 3 investors. Key investors include Gov.uk, Astellas Pharma, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available